Fortrea Holdings (FTRE) Intangibles (2022 - 2026)
Fortrea Holdings (FTRE) posted Intangibles of $601.7 million for Q1 2026, down 3.26% on a QoQ basis from $622.0 million in Q4 2025, and down 7.62% year-over-year from $651.3 million in Q1 2025.
Fortrea Holdings (FTRE) Intangibles (2022 - 2026) Analysis & Trends
Fortrea Holdings' Intangibles history runs 5 years deep, the most recent figure standing at $601.7 million for Q1 2026.
- Quarterly Intangibles fell 7.62% year-over-year to $601.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $601.7 million (down 7.62% YoY) and the FY2025 annual result came in at $622.0 million, down 5.14% from the prior year.
- Intangibles was $601.7 million for Q1 2026 at Fortrea Holdings, down from $622.0 million in the prior quarter.
- Across five years, Intangibles topped out at $823.3 million in Q4 2022 and bottomed at $601.7 million in Q1 2026.
- A 5-year average of $695.2 million and a median of $691.2 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2024 — Intangibles slipped 13.67% — and 2025, when it declined 5.14%.
- Fortrea Holdings' Intangibles stood at $823.3 million in 2022, then slipped by 11.56% to $728.1 million in 2023, then retreated by 9.94% to $655.7 million in 2024, then fell by 5.14% to $622.0 million in 2025, then fell by 3.26% to $601.7 million in 2026.
- Business Quant data shows FTRE's Intangibles at $601.7 million in Q1 2026, $622.0 million in Q4 2025, and $635.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 11,640.44 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 61.68 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 55.80 Mn |
| 10 | Fortrea Holdings | 1.79 Bn | 1.64 Bn | 123.60 Mn | 601.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 601.70 Mn |
| Dec 31, 2025 | 622.00 Mn |
| Sep 30, 2025 | 635.40 Mn |
| Jun 30, 2025 | 654.30 Mn |
| Mar 31, 2025 | 651.30 Mn |
| Dec 31, 2024 | 655.70 Mn |
| Sep 30, 2024 | 691.20 Mn |
| Jun 30, 2024 | 691.90 Mn |
| Mar 31, 2024 | 707.90 Mn |
| Dec 31, 2023 | 728.10 Mn |
| Sep 30, 2023 | 773.70 Mn |
| Jun 30, 2023 | 801.50 Mn |
| Dec 31, 2022 | 823.30 Mn |